$派格生物医药-B(_老虎社区_美港股上老虎

$派格生物医药-B(02565)$ 全球GLP-1类药物研发竞争白热化，任何临床数据上的相对劣势都可能被市场放大，派格生物其产品的差异化优势还是存在的

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":544292298044856,"tweetId":"544292298044856","gmtCreate":1773909363732,"gmtModify":1773909366099,"author":{"id":4184380269673420,"idStr":"4184380269673420","authorId":4184380269673420,"authorIdStr":"4184380269673420","name":"骏马飞驰吧","avatar":"https://static.tigerbbs.com/d3702f332c2e6980d8637b92198e2a1c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 全球GLP-1类药物研发竞争白热化，任何临床数据上的相对劣势都可能被市场放大，派格生物其产品的差异化优势还是存在的</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02565\">$派格生物医药-B(02565)$ </a> 全球GLP-1类药物研发竞争白热化，任何临床数据上的相对劣势都可能被市场放大，派格生物其产品的差异化优势还是存在的</p></body></html>","text":"$派格生物医药-B(02565)$ 全球GLP-1类药物研发竞争白热化，任何临床数据上的相对劣势都可能被市场放大，派格生物其产品的差异化优势还是存在的","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/544292298044856","repostId":0,"isVote":1,"tweetType":1,"viewCount":255,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02565"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":130,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/544292298044856"}